In vivo CD19 CAR T-cell therapy showed promising results in a feasibility study of five patients with refractory systemic lupus erythematosus.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/vivo-car-t-cell-therapy-shows-potential-refractory-sle-2025a1000qho?src=rss
Author :
Publish date : 2025-10-02 11:28:00
Copyright for syndicated content belongs to the linked Source.
